Koeter GH, Dekhuijzen PN, et al. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax 1992; 47:429-436. 59. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58:659-664. 60. Guyatt G H, Townsend M, Nogradi S, Pugsley SO, Keller JL, Newhouse MT. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med. 1988; 148:1949-1952. 61. Hanania NA, Sharafkhaneh A, Celli B, Decramer M, Lystig T, Kesten S, et al. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011; 12:6. 62. Mendella LA, Manfreda J, Warren CP, Anthonisen NR. Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med. 1982; 96:17-21. 63. Enright PL, Lebowitz MD, Cockroft DW. Physiologic measures: pulmonary function tests. Asthmaoutcome. Am J Respir Crit Care Med. 1994; 149:S9-18. 64. National Asthma Education Program. Expert panel report-guidelines for diagnosis and management of asthma. NIH. 1991. Publication 91-3042A. 65. Real Decreto 1971/1999 de 23 de diciembre, de reconocimiento, declaración y calificación del grado de minusvalía. Capítulo 4. 1999. 66. Zibrak JD, O’Donnell CR, Marton K. Indications for pulmonary function testing. Ann Intern Med. 1990; 112:763-771. 67. Lim TK, Ang SM, Rossing TH, Ingenito EP, Ingram RHJr. The effects of deep inhalation on maximal expiratory flow during intensive treatment of spontaneous asthmatic epi53
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.